Literature DB >> 19237221

Proliferative diabetic retinopathy-The influence of diabetes control on the activation of the intraocular molecule system.

Joanna Adamiec-Mroczek1, Jolanta Oficjalska-Młyńczak, Marta Misiuk-Hojło.   

Abstract

AIMS: Demonstrate the influence of type 2 diabetes control on the degree of retinal endothelial damage (vWF, E-selectin) and local increases in the concentrations of selected adhesion molecules (ICAM-1, VCAM-1, E-selectin) in proliferative diabetic retinopathy (PDR).
METHODS: Vitreous and serum samples were collected during vitrectomy from 19 patients with PDR and 15 patients who underwent vitrectomy for other reasons. Tests were performed using the ELISA method.
RESULTS: Serum and intraocular concentrations of ICAM-1, VCAM-1, E-selectin, vWF were considerably higher in the subjects with PDR than in the controls. In the vitreous, the increase in vWF depended on the elevated levels of vWF in the serum (r=0.905, p<0.001). E-selectin correlated with diastolic blood pressure (r=0.506, p=0.045). The concentrations of vWF and E-selectin in both samples were related to the significant increases in intraocular ICAM-1, ICAM-1, VCAM-1 in the serum of PDR patients. Increased VCAM-1 level in the vitreous correlated with the concentration of HbA(1)c (r=0.59, p=0.007).
CONCLUSIONS: Upon local and systemic damage to the endothelium there were significant increases in ICAM-1, VCAM-1, E-selectin. A significant positive correlation of VCAM-1 increase in the vitreous with HbA(1)c is an important argument for the influence of diabetes on immuno-inflammatory activation in the retinal microcirculation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237221     DOI: 10.1016/j.diabres.2009.01.012

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  14 in total

Review 1.  Inflammatory mediators in diabetic retinopathy: Deriving clinicopathological correlations for potential targeted therapy.

Authors:  Abhishek Sheemar; Deepak Soni; Brijesh Takkar; Soumyava Basu; Pradeep Venkatesh
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

2.  Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.

Authors:  Ying Chen; Yang Hu; Ti Zhou; Kevin K Zhou; Robert Mott; Mingyuan Wu; Michael Boulton; Timothy J Lyons; Guoquan Gao; Jian-xing Ma
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

3.  Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy.

Authors:  Dean F Loporchio; Emily K Tam; Jane Cho; Jaeyoon Chung; Gyungah R Jun; Weiming Xia; Marissa G Fiorello; Nicole H Siegel; Steven Ness; Thor D Stein; Manju L Subramanian
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

Review 4.  Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy.

Authors:  Daniel Gologorsky; Aristomenis Thanos; Demetrios Vavvas
Journal:  Mediators Inflamm       Date:  2012-09-17       Impact factor: 4.711

5.  Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes.

Authors:  Hyun Jeong Jeon; Hyung Jin Choi; Byong Hee Park; Yong Hee Lee; Taekeun Oh
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

6.  Leukocyte adhesion molecules in diabetic retinopathy.

Authors:  Kousuke Noda; Shintaro Nakao; Susumu Ishida; Tatsuro Ishibashi
Journal:  J Ophthalmol       Date:  2011-11-02       Impact factor: 1.909

7.  Effects of quercetin on the expression of MCP-1, MMP-9 and VEGF in rats with diabetic retinopathy.

Authors:  Bin Chen; Tao He; Yiqiao Xing; Ting Cao
Journal:  Exp Ther Med       Date:  2017-10-10       Impact factor: 2.447

8.  Proliferative diabetic retinopathy: predictive and preventive measures at hypoxia induced retinal changes.

Authors:  Tatjana Josifova; Ivna Plestina-Borjan; Paul Bernhard Henrich
Journal:  EPMA J       Date:  2010-04-01       Impact factor: 6.543

9.  Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus.

Authors:  Astha Jain; Sandeep Saxena; Vinay K Khanna; Rajendra K Shukla; Carsten H Meyer
Journal:  Mol Vis       Date:  2013-08-04       Impact factor: 2.367

10.  Interleukin-4 and melatonin ameliorate high glucose and interleukin-1β stimulated inflammatory reaction in human retinal endothelial cells and retinal pigment epithelial cells.

Authors:  Manyun Xie; Andina Hu; Yan Luo; Wei Sun; Xinqian Hu; Shibo Tang
Journal:  Mol Vis       Date:  2014-06-28       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.